An artist’s illustration of antibiotic selection processes driven by AI. Credit: The University of Texas at Austin In a hopeful sign for demand for more safe, effective antibiotics for humans, researchers at The University of Texas at Austin have leveraged artificial intelligence to develop a new drug that already is showing promise in animal trials. Publishing their results in Nature Biomedical Engineering , the scientists describe using a large language model—an AI tool like the one that powers ChatGPT—to engineer a version of a bacteria -killing drug that was previously toxic in humans, so that it would be safe to use. The prognosis for patients with dangerous bacterial infections has worsened in recent years as antibiotic-resistant bacterial strains spread and the development of new treatment options has stalled. However, […]
Original web page at medicalxpress.com
